Dr. Inge Hantson SRL

Dr. Inge Hantson reported total assets of 760,063 € at the end of the 2025 financial year (annual accounts filed with the NBB on 20 Jul 2026).

Company number (CBE) 0525.792.755 · VAT BE0525792755
2840 Rumst
active in Medical specialists activities (NACE 86220)
operating since 08 Apr 2013 (≈ 13 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Dr. Inge Hantson shows with a free account.

See the score
Profile
SRL since 2013
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result112,559 €
Equity666,055 €
Cash145,284 €
EBITDA170,681 €
Total assets760,063 €
The line marks its sector median: 72.2% (8672 companies).

Change 2022 → 2025: Equity +31 % Total assets +21 %

Accounts of the company itself (not consolidated).

The full file covers 10 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Dr. Inge Hantson's annual accounts

20252024202320222021
Net result112,559 €
Equity666,055 €
Cash145,284 €
EBITDA170,681 €
Total assets760,063 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 20 Jul 2026
  • Year ended 31 Dec 2024filed on 23 Jul 2025
  • Year ended 31 Dec 2023filed on 26 Jul 2024
  • Year ended 31 Dec 2022filed on 28 Jul 2023
  • Year ended 31 Dec 2021filed on 28 Jul 2022

Dr. Inge Hantson's financial analysis

Management and control of Dr. Inge Hantson

1 active director(s) in the register.

Dr. Inge Hantson's shareholders and holdings →

Dr. Inge Hantson's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0525.792.755
VAT number
BE0525792755
Peppol
Registered · 0208:0525792755 · as of 10 Nov 2026
Legal form
SRL
Incorporated
08 Apr 2013
Registered office
2840 Rumst
Latest accounts
2025 · filed on 20 Jul 2026
Activity
Medical specialists activities (NACE 86220)

Dr. Inge Hantson (SRL) has been based in Rumst since 2013, active in: medical specialists activities. For 2025, it reports a net profit of 112,559 € and equity of 666,055 €; its revenue is not published. Its solvency stands at 87.6%, above the median of its sector (72.2%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Dr. Inge Hantson

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Dr. Inge Hantson

What is the revenue of Dr. Inge Hantson?

Dr. Inge Hantson files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Dr. Inge Hantson?

In Belgium, the VAT number is the company number prefixed with BE: BE0525792755 for Dr. Inge Hantson, if the company is VAT-registered. Its company number (CBE) is 0525.792.755.

Where is the registered office of Dr. Inge Hantson?

According to the CBE register, the registered office of Dr. Inge Hantson is in 2840 Rumst.

What is the equity of Dr. Inge Hantson?

At the close of the 2025 financial year, the equity of Dr. Inge Hantson amounts to 666,055 €, a solvency of 87.6% of total assets.

Who manages Dr. Inge Hantson?

The register lists 1 active mandates at Dr. Inge Hantson. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Dr. Inge Hantson

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 24 Jul 2026

No credit card, no commitment.

What each plan unlocks →